Antitoxin treatments for necrotizing pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus;Traitements antitoxiniques et pneumopathies nécrosantes à Staphylococcus aureus sécréteurs de leucocidine de Panton-Valentine

Medecine et Maladies Infectieuses

Volumn 39, Issue 1, 2009, Pages 14-20

  Libert, N ^a   Batjom, E ^a   Cirodde, A ^a   de Rudnicki, S ^a   Grasser, L ^a   Borne, M ^a   Brinquin, L ^a  

^a University of Paris Descartes   (France)

Author keywords

Multiorgan failure; Necrotizing pneumonia; Panton Valentine leukocidin; Septic shock; Staphylococcus aureus

Indexed keywords

ANTITOXIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; LINEZOLID; METICILLIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; VANCOMYCIN;

FEVER; FURUNCULOSIS; HEMOPTYSIS; HUMAN; HYPOXEMIA; IMMUNOCOMPETENCE; LEUKOPENIA; LUNG ALVEOLUS; LUNG INFILTRATE; NECROSIS; OSTEOARTHROPATHY; PATHOPHYSIOLOGY; PNEUMONIA; REVIEW; SEPTIC SHOCK; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; ANTITOXINS; BACTERIAL TOXINS; CHILD; EXOTOXINS; HUMANS; LEUKOCIDINS; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCUS AUREUS;

EID: 57949111715     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.10.008     Document Type: Review

References (54)

1. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
2. Ferry T., Perpoint T., Mohammedi I., Descloux E., Vandenesch F., and Etienne J. Facteurs de virulence de Staphylococcus aureus et pronostic des infections staphylococciques sévères. Actual Reanim Urg (2006)
3. Prevost G., Cribier B., Couppie P., Petiau P., Supersac G., Finck-Barbançon V., et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 63 (1995) 4121-4129
4. Van de Velde H. Étude sur le mécanisme de la virulence du staphylocoque pyogène. Cellule 10 (1894) 401-410
5. Supersac G., Prevost G., and Piemont Y. Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins. Infect Immun 61 (1993) 580-587
6. Woodin A.M. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 75 (1960) 158-165
7. Kaneko J., Kimura T., Narita S., Tomita T., and Kamio Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes. Gene 215 (1998) 57-67
8. Colin D.A., Mazurier I., Sire S., and Finck-Barbançon V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect Immun 62 (1994) 3184-3188
9. Kaneko J., and Kamio Y. Bacterial two-component and hetero-heptameric pore forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68 (2004) 981-1003
10. Prevost G., Couppie P., Prevost P., Gayet S., Petiau P., Cribier B., et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42 (1995) 237-245
11. Holmes A., Ganner M., McGuane S., Pitt T.L., Cookson B.D., and Kearns A.M. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 43 (2005) 2384-2390
12. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
13. Tristan A., Bes M., Meugnier H., Lina G., Bozdogan B., Courvalin P., et al. Global distribution of Panton-Valentine leukocidin: positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 13 (2007) 594-600
14. Naas T., Fortineau N., Spicq C., Robert J., Jarlier V., and Nordmann P. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital. J Hosp Infect 61 (2005) 321-329
15. Cribier B., Prévost G., Couppie P., Finck-Barbançon V., Grosshans E., and Piémont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 185 (1992) 175-180
16. Couppie P., Cribier B., and Prévost G. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 130 (1994) 1208-1209
17. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., and EMERGEncy ID Net Study Group. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
18. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
19. Issartel B., Tristan A., Lechevallier S., Bruyère F., Lina G., Garin B., et al. Frequent carriage of Panton-Valentine leucocidin genes by Staphylococcus aureus isolates from surgically drained abscesses. J Clin Microbiol 43 (2005) 3203-3207
20. Miller L.G., Perdreau-Remington F., Rieg G., Mehdi S., Perlroth J., Bayer A.S., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005) 1445-1453
21. Gillet Y., Dohin B., Dumitrescu O., Lina G., Vandenesch F., Etienne J., et al. Infections ostéoarticulaires à staphylocoques dorés sécréteurs de la leucocidine de Panton-Valentine. Arch Pediatr 14 (2007) S102-S107
22. Adem P., Montgomery C., Husain A.N., Koogler T.K., Arangelovich V., Humilier M., et al. Staphylococcus aureus sepsis and the Waterhouse-Fridericjsen syndrome in children. N Engl J Med 353 (2005) 1245-1251
23. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359 (2002) 753-759
24. Gillet Y., Vanhems P., Lina G., Bes M., Vandenesch F., Floret D., et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 45 (2007) 315-321
25. Gonzalez B.E., Hulten K.G., Dishop M.K., Lamberth L.B., Hammerman W.A., Mason Jr. E.O., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 41 (2005) 583-590
26. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza: Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325-29.
27. de Bentzmann S., Tristan A., Etienne J., Brousse N., Vandenesch F., and Lina G. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 190 (2004) 1506-1515
28. Konig B., Prevost G., Pimont Y., and Konig W. Effects of Staphylococcus aureus leukocidins on Inflammatory Mediator Release from human Granulocytes. J Infect Dis 171 (1995) 607-613
29. Labandeira-Rey M., Couzon F., Boisset S., Brown E.L., Bes M., Benito Y., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315 (2007) 1130-1133
30. Gomez M.I., Lee A., Reddy B., Muir A., Soong G., Pitt A., et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 10 (2004) 842-848
31. Genestier A.L., Michallet M.C., Prevost G., Bellot G., Chalabreysse L., Peyrol S., et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115 (2005) 3117-3127
32. Torell E., Molin D., Tano E., Ehrenborg C., and Ryden C. Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL). Scand J Infect Dis 37 (2005) 902-904
33. Frazee B.W., Salz T.O., Lambert L., and Perdreau-Remington F. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 46 (2005) 401-404
34. Vayalumkal J.V., Whittingham H., Vanderkooi O., Stewart T.E., Low D.E., Mulvey M., et al. Necrotizing pneumonia and septic shock: suspecting CA-MRSA in patients presenting to Canadian emergency departments. CJEM 9 (2007) 300-303
35. Peleg A.Y., and Munckhof W.J. Fatal necrotising pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (MRSA). Med J Aust 181 (2004) 228-229
36. Risson D.C., O'Connor E.D., Guard R.W., Schooneveldt J.M., and Nimmo G.R. A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust 186 (2007) 479-480
37. Laifer G., Frei R., Adler H., and Fluckiger U. Necrotising pneumonia complicating a nasal furuncle. Lancet 367 (2006) 1628
38. Reischl U., Tuohy M.J., Hall G.S., Procop G.W., Lehn N., and Linde H. Rapid detection of Panton-Valentine leukocidin-positive Staphylococcus aureus by real-time PCR targeting the lukS-PV gene. Eur J Clin Microbiol Infect Dis 26 (2007) 131-135
39. Dumitrescu O., Boisset S., Badiou C., Bes M., Benito Y., Reverdy M.E., et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 51 (2007) 1515-1519
40. Stevens D.L., Ma Y., Salmi D.B., McIndoo E., Wallace R.J., and Bryant A.E. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195 (2007) 202-211
41. Doss S.A., Tillotson G.S., and Amyes S.G. Effect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus. J Appl Bacteriol 75 (1993) 123-128
42. Schlievert P.M., and Kelly J.A. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis 149 (1984) 471
43. Gemmell C.G., and Ford C.W. Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid. J Antimicrob Chemother 50 (2002) 665-672
44. Micek S.T., Dunne M., and Kollef M.H. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128 (2005) 2732-2738
45. Weigelt J., Itani K., Stevens D., Lau W., Dryden M., Knirsch C, and Linezolid CSSTI Study Group. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 49 (2005) 2260-2266
46. Cruciani M., Gatti G., Lazzarini L., Furlan G., Broccali G., Malena M., et al. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 38 (1996) 865-869
47. Scheetz M.H., Wunderink R.G., Postelnick M.J., and Noskin G.A. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy 26 (2006) 539-550
48. Levin T.P., Suh B., Axelrod P., Truant A.L., and Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 49 (2005) 1222-1224
49. Schefold J.C., Esposito F., Storm C., Heuck D., Krüger A., Jörres A., et al. Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report. J Med Case Reports 1 (2007) 165
50. Silverman J.A., Mortin L.I., Vanpraagh A.D., Li T., and Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 191 (2005) 2149-2152
51. Dumitrescu O., Badiou C., Bes M., Reverdy M.E., Vandenesch F., Etienne J., et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect 14 (2008) 384-389
52. Gauduchon V., Cozon G., Vandenesch F., Genestier A.L., Eyssade N., Peyrol S., et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189 (2004) 346-353
53. Angstwurm M.W., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., Abel P., et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35 (2007) 118-126
54. Creech C.B., Johnson B.G., Bartilson R.E., Yang E., and Barr F.E. Increasing use of extracorporeal life support in methicillin-resistant Staphylococcus aureus sepsis in children. Pediatr Crit Care Med 8 (2007) 231-235